Application of Primary/Secondary Circulating Tumor Cells for the Prediction of Biochemical Recurrence in Nonmetastatic Prostate Cancer Patients following Radical …
L Cao, P Hao, D Lin, Y Li, T Hu, T Cai… - BioMed Research …, 2021 - Wiley Online Library
Background. Circulating tumor cells (CTCs) have been regarded as an independent
prognostic marker for metastatic castration‐resistant prostate cancer (mCRPC). Its …
prognostic marker for metastatic castration‐resistant prostate cancer (mCRPC). Its …